Intraepidermal epidermotropic metastatic melanoma: a clinical and histopathological mimicker of melanoma in situ occurring in multiplicity
Cutaneous melanoma represents a lethal skin cancer that is responsible for 80% of skin cancer mortality. 1 Metastatic melanoma progression typically evolves from local cutaneous growth to regional metastasis involving lymph node(s) or in-transit metastasis, and later disseminated metastatic disease may involve skin or any visceral organ. 2 Cutaneous melanoma metastases usually involve the dermis and subcutaneous tissue and spare the overlying epidermis. 3 Rarely, metastatic melanomas can show prominent epidermotropism, mimicking primary melanoma. Epidermotropic metastatic melanoma represents a recognized pathological variant. Its recognition is particularly challenging as its clinical and histopathological appearance can simulate primary melanoma. 4 This distinction is crucial in the prognosis and treatment approach to affected patients. In 1978, Kornberg and colleagues proposed histopathological criteria for the diagnosis of epidermotropic metastatic melanoma, 5 which are still used at the present time. However, in the past few decades, the morphological spectrum of epidermotropic metastatic melanoma has broadened and additional criteria have been added. 4,6 -8 Herein, we report a patient whose melanoma recurred with 46 epidermotropic metastases that were wholly intraepidermal. The patient also suffered from multifocal asymptomatic gastrointestinal metastases.
Case report
In 2002, a 67-year-old male was diagnosed with a non-ulcerated superficial spreading melanoma (stage IB, T2 N0 M0, Breslow's thickness 1.3 mm, Clark's level III) involving the lower back (Fig. 1) . Sentinel lymph node evaluation was not performed. After wide excision (1 cm), adjuvant immunotherapy with A B Fig. 1 . Histopathology of the primary melanoma of the back, which was excised in November 2002. The proliferation was broad and markedly asymmetrical (A: hematoxylin and eosin, ×40). There was a population of atypical melanocytes with pagetoid spread and epidermal consumption (B: hematoxylin and eosin, ×100).
Fig. 2.
Histopathology of a pigmented lesion of the thigh that appeared 6 years after the excision of the primary melanoma. There was a wholly intraepidermal proliferation of atypical melanocytes with pagetoid spread, indistinguishable from melanoma in situ (hematoxylin and eosin, ×40).
interferon-alpha (3 millions IU, thrice weekly) was started and maintained over 12 months. He was regularly followed and remained free from disease recurrence up until February 2009, when an irregularly shaped and highly pigmented macule appeared on his left thigh. His environmental exposure history was significant for several sunburns before 20 years of age and family history was remarkable for melanoma in two siblings. Histopathological examination of the new pigmented lesion was interpreted as melanoma in situ (Fig. 2) . Subsequently, several small pigmented macules appeared in crops on the back (Fig. 3) . The most irregular ones were excised and all biopsy specimens showed markedly atypical melanocytes arranged in irregular nests and solitary units at all levels of epidermis, mimicking melanoma in situ. Neither dermal involvement nor invasion of vascular or lymphatic spaces was detected (Fig. 4) . Those judgments were supported by Melan-A and CD31 stains. New crops of pigmented lesions appeared on the back, arms and legs. Most of them were small (less than 5 mm of diameter), brownish, well-defined, symmetric and macular. A total of 46 lesions were excised during a 9-month period. Histopathological findings were similar in all specimens, consisting of an exclusively intraepidermal proliferation of large atypical melanocytes with increased nuclear to cytoplasmatic ratio and prominent nucleoli. Those findings were compatible with melanoma in situ, although many lesions were small, symmetric and circumscribed (Fig. 5) .
Dermoscopically, the lesions were extremely polymorphic. Most of the excised macules had a lightbrown symmetric homogeneous pattern with only few darker dots at the periphery. Frequently, a regular starburst pattern was also observed. In some lesions, melanoma-specific criteria were present, particularly blue-white structures and irregular blotches (Fig. 6) .
The patient underwent staging with inguinal nodal ultrasonography; computed tomography (CT) of the head, chest, abdomen and pelvis; brain magnetic resonance (MR) and positron emission tomography/CT (PET-CT). Distant metastases were not identified by this testing. Results of routine laboratorial evaluation, including lactate dehydrogenase (LDH) and S-100 protein, were unremarkable. Mucosal and uveal involvement by melanoma was also excluded. Even though the patient was asymptomatic, an upper endoscopy was performed that showed pigmented macules and ulcerated nodules involving the stomach and duodenum mucosa. The biopsy specimens revealed metastatic melanoma within superficial mucosa (Fig. 7) . This diagnosis was supported by positive immunostaining with HMB-45. Surgical resection of the stomach and proximal duodenum was considered, but surgery was rejected after detection of multifocal metastatic melanoma throughout the entire length of the jejunum and ileum by capsule videoendoscopy.
Molecular analysis was also performed. Genomic DNA was extracted from peripheral blood nucleated cells using conventional procedures. No germline point mutations or exonic rearrangements were found in the CDKN2A gene or point mutations in CDK4 ( codon 24). Fluorescence in situ hybridization (FISH) analysis was completed using paraffinembedded sections of the primary lesion and a commercially available probe to target the gene CDKN2A in chromosome band 9p21 and the centromere of chromosome 9 (LSI CDKN2A /CEP 9 ProbeVysis/Abbott). Monosomy of chromosome 9 (including loss of a copy of the CDKN2A gene) was found in the primary tumor. We also performed mutation analysis of BRAF (codon 600) in paraffin-embedded sections of the primary tumor sample and in freshly collected biopsy specimens from seven presumed secondary lesions of the skin. A BRAF V600E mutation was detected in the primary tumor sample but not in the seven skin biopsy specimens analyzed. Given this unexpected finding, we looked for monosomy 9 and BRAF codon 600 in paraffin-embedded tissue sections of five distinct and separate secondary skin lesions (molecular analysis was completed after macrodissection to avoid contamination with normal cells) and indeed found that the primary tumor and all the analyzed secondary lesions shared the chromosome 9 monosomy and BRAF V600E mutation.
During ongoing follow up, albeit with the continuous appearance of new pigmented lesions until November 2009, the patient remained asymptomatic with good general status. A multidisciplinary team decided to delay initiation of systemic chemotherapy and/or chemoimmunotherapy and wait for the beginning of a new clinical trial recruiting patients with stage IV malignant melanoma.
In February of 2010, the patient died as a result of a large aortic thrombus with an extensive systemic embolization affecting the brain, heart, spleen and kidney. The patient's family refused an autopsy. 
Discussion
Cutaneous metastases of melanoma have a variable appearance. Papules, nodules and tumors commonly involve the dermis and subcutis and less frequently involve the overlying epidermis. 3 Metastases with epidermal involvement have been designated epidermotropic metastatic melanoma and usually present as multiple, symmetric, small lesions occurring in crops located in the same region as the primary melanoma. Less frequently, widely disseminated lesions can be seen. 3 -6 Histopathological criteria for defining epidermotropic metastatic melanoma have evolved over the years. The distinction between metastatic and primary melanoma was initially based on the absence of involvement of the overlying epithelium. 9 In 1978, Kornberg and colleagues developed specific histopathological features that favored the diagnosis of epidermotropic metastatic melanoma, including: (a) dermal involvement equal or greater than epidermal involvement; (b) junctional epidermal involvement not extending beyond the edge of the dermal component; (c) atypical melanocytes filling the papillary dermis with thinning of epidermis; (d) widening of papillae with the formation of an epithelial collarette; and (e) the identification of atypical melanocytes in vascular and lymphatic spaces. 5 Subsequently, epidermotropic metastatic melanoma with pagetoid spread of atypical melanocytes beyond the lateral limits of the dermal component of dermal melanoma was described. 6, 10, 11 Several reports also suggested that angiotropism is suggestive of metastatic disease. 7, 12 Immunohistochemistry may be useful as a tool for distinguishing epidermotropic metastatic melanoma and multiple primary melanomas in situ, but the approach lacks specificity: metallothionein expression is strongly expressed by epidermotropic metastatic melanoma but is also expressed by Spitz nevi. In epidermotropic metastases, the intensity of HMB-45 staining is greater than that of S-100, but this phenotype does not exclude primary melanoma. 4, 13 Abernethy et al. reported two patients with widespread epidermotropic metastatic melanoma, including classic lesions with intraepidermal extension beyond the intradermal component and 10 lesions with only epidermal involvement simulating melanoma in situ. 13 In contrast to previous reports, our patient's lesions all showed identical histopathology with exclusively epidermal involvement and no detectable dermal disease. In this setting, the distinction between epidermotropic metastatic melanoma and multiple primary melanomas is virtually impossible by light microscopy. However, the diagnosis of There is a uniform diffuse brown lesion with a few darker dots throughout and at its periphery (A). A multicomponent pattern lesion has significant asymmetry of color and structure; blue-white structures, irregular dots and irregular blotches are seen (B). Depicted is a globular pattern lesion with variously sized dark brown globules; a blue-white veil is also noted at the periphery (C). A regular and symmetric starburst pattern is also recognizable (D).
epidermotropic metastatic melanoma was suggested by clues expressed by most of our patient's lesions, including: (a) multiple disseminated lesions appearing in crops; (b) lesions of small size; and (c) lesional symmetry and circumscription. Regression of the dermal component is unlikely to be the explanation of this epidermal-only pattern. Rather, the phenomenon of epidermotropic metastasis probably represents hematogenous spread with only transient or minimal dermal involvement. The survival of patients with melanoma is heavily dependent on the stage of the malignancy, and patients with epidermotropic metastases have a poor prognosis and distant metastases involving other organs are a frequent finding. 14 PET combined with CT imaging (PET-CT) has become a major diagnostic tool in the detection of metastatic disease, as the technique improves the identification of deep soft tissue, lymph node and visceral metastases. 15, 16 PET-CT has been also proposed as the method of choice in detecting gastrointestinal melanoma metastases, which frequently are underdiagnosed by standard endoscopic techniques. 17, 18 However, small metastatic deposits need to achieve a certain size to be detected by PET-CT. 15 In this case, the diagnosis of metastatic melanoma was particularly challenging. While the presence of widely disseminated small pigmented lesions appearing in crops in a patient with a previous diagnosis of melanoma suggested epidermotropic metastatic melanoma as a possibility, a staging evaluation (including a PET-CT) was negative for distant metastatic disease. In addition, histopathology was unable to discriminate epidermotropic metastases from multiple melanomas in situ and dermoscopy also failed to show unequivocal dermoscopic melanoma criteria. Indeed, few studies are available regarding the dermoscopic features of cutaneous metastatic melanoma. 19 -22 In a study with 130 cutaneous melanoma metastases, the saccular and vascular patterns as well as the presence of pigmentary halo and peripheral gray spots have been proposed as the most significant dermoscopic elements supporting interpretation as metastatic melanoma. 19 To the best of our knowledge, the dermoscopic results of epidermotropic metastatic melanoma have not been previously described. In our case, the dermoscopic findings were polymorphic and included reticular, homogeneous, globular and spitzoid patterns simulating melanocytic nevi or primary cutaneous melanoma. These heterogeneous findings suggest that the diagnosis of epidermotropic metastatic melanoma cannot reliably be made on the basis of dermoscopic features alone. Genetic analysis of melanoma can provide additional information of use in the distinction of metastatic lesions from independent primaries. 23 -26 Although genetic intra-and intertumoral heterogeneity is a frequent feature in melanoma, it would be expected that a primary melanoma and its metastases would share one or more genetic alterations. Loss of heterozygosity (LOH) and X-chromosome inactivation analysis studies suggest that metastatic lesions in most melanoma patients are clonally related to their primary lesions. 23, 25, 27 In our patient's tissue, the somatic mutation V600E in the BRAF gene and monosomy 9 were identified in the primary melanoma. Mutations in BRAF have been described in 40-80% of melanomas and V600E is the most common observed mutation. Mutations in BRAF appear to represent an early event in melanoma progression and are usually retained in secondary lesions. 23, 28 In our case, the V600E mutation was not initially detected in any of the seven freshly collected metastases, which were analyzed without macrodissection (and thus contaminating normal tissue may have obscured the molecular results). However, the subsequent use of FISH in paraffinembedded tissue sections and molecular analysis after macrodissection to avoid contamination allowed the demonstration of a molecular relationship between five presumed epidermotropic metastases and the original primary melanoma. No evidence of hereditary predisposition associated with germline mutations of CDKN2A or CDK4, as can be seen in familial and multiple primary melanoma, was found. 29, 30 .
We therefore conclude that the 46 pigmented lesions affecting our patient represent intraepidermal epidermotropic metastatic melanoma and not multiple examples of primary melanoma in situ. The clinical appearance of the lesions in conjunction with atypical dermoscopic findings, the presence of multiple gastrointestinal metastases, and the genetic findings strengthen this assertion. Our case shows that histopathology alone can be insufficient to distinguish intraepidermal epidermotropic metastatic melanoma from multiple primary lesions. Its recognition should be based on correlation with clinical, dermoscopic, histopathological and genetic findings.
